EYLEA 40mg/ml solution for injection in pre-filled syringe BAYER
aflibercept Indicated for: macular degeneration; diabetic macular edema
S01LA05 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
letter E · page 58
aflibercept Indicated for: macular degeneration; diabetic macular edema
S01LA05 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
ezetimibe Indicated for: dyslipidemia
ezetimibe Indicated for: dyslipidemia
ezetimibe Indicated for: dyslipidemia
ezetimibe Indicated for: dyslipidemia
ezetimibe Indicated for: dyslipidemia
ezetimibe Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe + atorvastatin Indicated for: dyslipidemia
ezetimibe Indicated for: dyslipidemia
sodium sulfate + magnesium sulfate + potassium sulfate Indicated for: constipation
mirdametinib Indicated for: cancer
mirdametinib Indicated for: cancer
mirdametinib Indicated for: cancer